losartan has been researched along with pci 32765 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foster, H; Foster, R; Philippou, H; Wilson, C | 1 |
| Cheng, Y; Du, Y; Han, C; Huang, N; Li, G; Song, C | 1 |
1 review(s) available for losartan and pci 32765
| Article | Year |
|---|---|
Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies.
Topics: | 2022 |
1 other study(ies) available for losartan and pci 32765
| Article | Year |
|---|---|
Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis.
Topics: Binding Sites; Biological Products; Humans; Ligands; Losartan; Molecular Dynamics Simulation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Signal Transduction; Small Molecule Libraries; Thrombosis | 2020 |